🇺🇸 FDA
Pipeline program

LacTEST 0,45 g polvo para solución oral.

VPH-GXL-2025-2

Approved small_molecule active

Quick answer

LacTEST 0,45 g polvo para solución oral. for Lactose intolerance is a Approved program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Lactose intolerance
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials